| 0.931 | 0.003 | 0.931 | Hypolipemic | | |
| 0.821 | 0.004 | 0.821 | Cholesterol antagonist | | |
| 0.762 | 0.003 | 0.762 | Alcohol oxidase inhibitor | | |
| 0.753 | 0.009 | 0.753 | Cyclophilin D inhibitor | | |
| 0.71 | 0.003 | 0.71 | Alpha-N-acetylglucosaminidase inhibitor | | |
| 0.697 | 0.008 | 0.697 | Aldehyde oxidase inhibitor | | |
| 0.695 | 0.007 | 0.695 | Vasodilator, peripheral | | |
| 0.658 | 0.002 | 0.658 | Leukotriene B4 receptor 1 antagonist | | |
| 0.651 | 0.005 | 0.651 | Platelet antagonist | | |
| 0.645 | 0.012 | 0.645 | Antithrombotic | | |
| 0.604 | 0.008 | 0.604 | Hypoglycemic | | |
| 0.599 | 0.015 | 0.599 | 5 Hydroxytryptamine release stimulant | | |
| 0.596 | 0.021 | 0.596 | Antiobesity | | |
| 0.559 | 0.008 | 0.559 | Vasodilator | | |
| 0.532 | 0.012 | 0.532 | Vasodilator, coronary | | |
| 0.523 | 0.003 | 0.523 | Farnesoid X receptor antagonist | | |
| 0.536 | 0.073 | 0.536 | Antiinflammatory | | |
| 0.468 | 0.006 | 0.468 | Lipid peroxidase inhibitor | | |
| 0.457 | 0.003 | 0.457 | Succinate dehydrogenase inhibitor | | |
| 0.488 | 0.036 | 0.488 | 5 Hydroxytryptamine release inhibitor | | |
| 0.448 | 0.014 | 0.448 | Peroxidase inhibitor | | |
| 0.49 | 0.064 | 0.49 | Caspase 9 stimulant | | |
| 0.438 | 0.018 | 0.438 | Interleukin 2 agonist | | |
| 0.42 | 0.004 | 0.42 | Cholesterol synthesis inhibitor | | |
| 0.421 | 0.011 | 0.421 | Non-steroidal antiinflammatory agent | | |
| 0.423 | 0.016 | 0.423 | Interleukin agonist | | |
| 0.455 | 0.052 | 0.455 | Transcription factor NF kappa B inhibitor | | |
| 0.407 | 0.004 | 0.407 | ABCA1 expression enhancer | | |
| 0.426 | 0.042 | 0.426 | Immunostimulant | | |
| 0.43 | 0.053 | 0.43 | Immunosuppressant | | |
| 0.432 | 0.059 | 0.432 | Histamine release inhibitor | | |
| 0.366 | 0.001 | 0.366 | ATP citrate lysase inhibitor | | |
| 0.369 | 0.004 | 0.369 | Leukotriene synthesis inhibitor | | |
| 0.413 | 0.056 | 0.413 | GABA C receptor rho-3 antagonist | | |
| 0.36 | 0.004 | 0.36 | Adenylate kinase inhibitor | | |
| 0.359 | 0.004 | 0.359 | Ferrochelatase inhibitor | | |
| 0.351 | 0.004 | 0.351 | Prostaglandin EP2 antagonist | | |
| 0.348 | 0.004 | 0.348 | Electron transport complex I inhibitor | | |
| 0.352 | 0.01 | 0.352 | Gastrin inhibitor | | |
| 0.353 | 0.014 | 0.353 | Phospholipase C inhibitor | | |
| 0.38 | 0.044 | 0.38 | Spasmolytic | | |
| 0.365 | 0.031 | 0.365 | Sodium/bile acid cotransporter inhibitor | | |
| 0.341 | 0.007 | 0.341 | GABA C receptor agonist | | |
| 0.338 | 0.005 | 0.338 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | | |
| 0.33 | 0.004 | 0.33 | Triose-phosphate isomerase inhibitor | | |
| 0.366 | 0.042 | 0.366 | Antioxidant | | |
| 0.328 | 0.005 | 0.328 | AMP-activated protein kinase stimulant | | |
| 0.319 | 0.003 | 0.319 | Diacylglycerol O-acyltransferase 1 inhibitor | | |
| 0.314 | 0.005 | 0.314 | Phosphofructokinase-1 inhibitor | | |
| 0.359 | 0.052 | 0.359 | Apoptosis antagonist | | |
| 0.345 | 0.039 | 0.345 | Interleukin antagonist | | |
| 0.316 | 0.014 | 0.316 | Hemostatic | | |
| 0.328 | 0.033 | 0.328 | 5 Hydroxytryptamine uptake stimulant | | |
| 0.295 | 0.004 | 0.295 | Leukotriene antagonist | | |
| 0.322 | 0.031 | 0.322 | Platelet aggregation inhibitor | | |
| 0.285 | 0.002 | 0.285 | Acyl-CoA dehydrogenase inhibitor | | |
| 0.293 | 0.013 | 0.293 | Insulin secretagoues | | |
| 0.307 | 0.03 | 0.307 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.282 | 0.006 | 0.282 | Glutamate dehydrogenase inhibitor | | |
| 0.279 | 0.01 | 0.279 | Expectorant | | |
| 0.363 | 0.095 | 0.363 | Antibacterial | | |
| 0.267 | 0.003 | 0.267 | Prostaglandin agonist | | |
| 0.305 | 0.042 | 0.305 | DNA synthesis inhibitor | | |
| 0.342 | 0.086 | 0.342 | Toll-Like receptor agonist | | |
| 0.258 | 0.003 | 0.258 | Leukotriene B4 antagonist | | |
| 0.378 | 0.124 | 0.378 | Apoptosis agonist | | |
| 0.258 | 0.005 | 0.258 | Carbamoyl phosphate synthetase inhibitor | | |
| 0.274 | 0.021 | 0.274 | Protein kinase stimulant | | |
| 0.283 | 0.032 | 0.283 | P-glycoprotein inhibitor | | |
| 0.267 | 0.02 | 0.267 | Antipruritic | | |
| 0.27 | 0.025 | 0.27 | Insulin sensitizer | | |
| 0.266 | 0.025 | 0.266 | Interferon gamma antagonist | | |
| 0.293 | 0.053 | 0.293 | Superoxide dismutase inhibitor | | |
| 0.245 | 0.007 | 0.245 | GABA C receptor antagonist | | |
| 0.313 | 0.075 | 0.313 | Immunomodulator | | |
| 0.241 | 0.005 | 0.241 | Glutamate decarboxylase inhibitor | | |
| 0.252 | 0.018 | 0.252 | Aldehyde dehydrogenase inhibitor | | |
| 0.237 | 0.005 | 0.237 | Adenylate cyclase stimulant | | |
| 0.269 | 0.038 | 0.269 | Hepatoprotectant | | |
| 0.269 | 0.039 | 0.269 | Growth hormone agonist | | |
| 0.252 | 0.023 | 0.252 | Phospholipase A2 inhibitor | | |
| 0.232 | 0.003 | 0.232 | Aconitate hydratase inhibitor | | |
| 0.23 | 0.004 | 0.23 | Prostaglandin F2 alpha antagonist | | |
| 0.237 | 0.012 | 0.237 | Toll-Like receptor 2 antagonist | | |
| 0.228 | 0.004 | 0.228 | Acetyl-CoA transferase inhibitor | | |
| 0.231 | 0.01 | 0.231 | Catalase inhibitor | | |
| 0.228 | 0.013 | 0.228 | Arachidonic acid antagonist | | |
| 0.22 | 0.005 | 0.22 | Peroxisome proliferator-activated receptor gamma agonist | | |
| 0.217 | 0.003 | 0.217 | Thromboxane antagonist | | |
| 0.257 | 0.047 | 0.257 | Anesthetic general | | |
| 0.21 | 0.007 | 0.21 | GABA C receptor rho-1 antagonist | | |
| 0.22 | 0.017 | 0.22 | Aminopeptidase B inhibitor | | |
| 0.212 | 0.011 | 0.212 | Mucolytic | | |
| 0.214 | 0.017 | 0.214 | Microtubule formation inhibitor | | |
| 0.23 | 0.032 | 0.23 | Melanin inhibitor | | |
| 0.261 | 0.065 | 0.261 | Angiogenesis stimulant | | |
| 0.198 | 0.003 | 0.198 | Thromboxane A2 antagonist | | |
| 0.205 | 0.011 | 0.205 | Vanilloid 1 agonist | | |
| 0.199 | 0.006 | 0.199 | Biliverdin reductase inhibitor | | |
| 0.209 | 0.018 | 0.209 | Interleukin 1b antagonist | | |
| 0.231 | 0.04 | 0.231 | Lipocortins synthesis antagonist | | |
| 0.243 | 0.053 | 0.243 | Nitric oxide antagonist | | |
| 0.248 | 0.059 | 0.248 | Psychostimulant | | |
| 0.345 | 0.156 | 0.345 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | | |
| 0.194 | 0.007 | 0.194 | Prostaglandin antagonist | | |
| 0.238 | 0.053 | 0.238 | Platelet adhesion inhibitor | | |
| 0.235 | 0.053 | 0.235 | DNA methyltransferase I inhibitor | | |
| 0.191 | 0.011 | 0.191 | NADH dehydrogenase inhibitor | | |
| 0.293 | 0.115 | 0.293 | Toll-Like receptor 7 agonist | | |
| 0.203 | 0.029 | 0.203 | Cell wall synthesis inhibitor | | |
| 0.178 | 0.005 | 0.178 | Peroxisome proliferator-activated receptor alpha agonist | | |
| 0.179 | 0.007 | 0.179 | Ca2+-transporting ATPase inhibitor | | |
| 0.173 | 0.004 | 0.173 | Fumarate hydratase inhibitor | | |
| 0.187 | 0.02 | 0.187 | UDP-glucose 4-epimerase inhibitor | | |
| 0.259 | 0.094 | 0.259 | Lipoxygenase inhibitor | | |
| 0.18 | 0.015 | 0.18 | Porphobilinogen synthase inhibitor | | |
| 0.173 | 0.009 | 0.173 | Phenylalanine 4-hydroxylase inhibitor | | |
| 0.173 | 0.009 | 0.173 | Aminopeptidase I inhibitor | | |
| 0.174 | 0.011 | 0.174 | Toll-Like receptor 4 antagonist | | |
| 0.221 | 0.058 | 0.221 | Neurotrophic factor enhancer | | |
| 0.178 | 0.015 | 0.178 | Histidine decarboxylase inhibitor | | |
| 0.277 | 0.116 | 0.277 | Calcium channel activator | | |
| 0.202 | 0.043 | 0.202 | Amylase inhibitor | | |
| 0.193 | 0.037 | 0.193 | Bone formation stimulant | | |
| 0.157 | 0.004 | 0.157 | Mannosidase inhibitor | | |
| 0.153 | 0.001 | 0.153 | HMG CoA reductase inhibitor | | |
| 0.186 | 0.034 | 0.186 | Neurotrophic factor | | |
| 0.169 | 0.018 | 0.169 | Sphingomyelinase inhibitor | | |
| 0.158 | 0.009 | 0.158 | Ornithine carbamoyltransferase inhibitor | | |
| 0.162 | 0.013 | 0.162 | Anabolic | | |
| 0.169 | 0.02 | 0.169 | TRPA1 agonist | | |
| 0.17 | 0.022 | 0.17 | Protease inhibitor | | |
| 0.22 | 0.074 | 0.22 | RNA-directed DNA polymerase inhibitor | | |
| 0.19 | 0.045 | 0.19 | NOS3 expression enhancer | | |
| 0.214 | 0.07 | 0.214 | DNA methylase inhibitor | | |
| 0.174 | 0.032 | 0.174 | Cathepsin H inhibitor | | |
| 0.219 | 0.077 | 0.219 | Peptidyltransferase inhibitor | | |
| 0.144 | 0.003 | 0.144 | Glucose-6-phosphate isomerase inhibitor | | |
| 0.144 | 0.003 | 0.144 | Prostacyclin agonist | | |
| 0.142 | 0.003 | 0.142 | Prostaglandin E2 agonist | | |
| 0.147 | 0.011 | 0.147 | Vanilloid agonist | | |
| 0.17 | 0.034 | 0.17 | Cyclooxygenase 3 inhibitor | | |
| 0.139 | 0.004 | 0.139 | Thromboxane synthase inhibitor | | |
| 0.145 | 0.012 | 0.145 | Argininosuccinate synthase inhibitor | | |
| 0.176 | 0.044 | 0.176 | Interleukin 1 antagonist | | |
| 0.202 | 0.07 | 0.202 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | | |
| 0.137 | 0.005 | 0.137 | Leukotriene D4 antagonist | | |
| 0.184 | 0.053 | 0.184 | ATPase inhibitor | | |
| 0.132 | 0.003 | 0.132 | Leukotriene C antagonist | | |
| 0.132 | 0.003 | 0.132 | Prostaglandin EP4 agonist | | |
| 0.17 | 0.041 | 0.17 | Anesthetic local | | |
| 0.147 | 0.021 | 0.147 | Electrolyte absorption antagonist | | |
| 0.18 | 0.054 | 0.18 | Interleukin 6 antagonist | | |
| 0.176 | 0.054 | 0.176 | Neurotensin receptor agonist | | |
| 0.138 | 0.015 | 0.138 | Ornithine decarboxylase inhibitor | | |
| 0.204 | 0.082 | 0.204 | Nitric-oxide synthase stimulant | | |
| 0.179 | 0.057 | 0.179 | Protein-tyrosine phosphatase inhibitor | | |
| 0.138 | 0.019 | 0.138 | Transcription factor NF kappa B stimulant | | |
| 0.219 | 0.103 | 0.219 | Cardiotonic | | |
| 0.156 | 0.041 | 0.156 | Adenylate cyclase inhibitor | | |
| 0.177 | 0.064 | 0.177 | Thrombolytic | | |
| 0.16 | 0.046 | 0.16 | Sphingosine 1-phosphate receptor 5 antagonist | | |
| 0.152 | 0.04 | 0.152 | Cystathionine beta-synthase inhibitor | | |
| 0.12 | 0.013 | 0.12 | Glycine receptor agonist | | |
| 0.111 | 0.005 | 0.111 | Nitric oxide donor | | |
| 0.117 | 0.01 | 0.117 | Peroxisome proliferator-activated receptor gamma antagonist | | |
| 0.203 | 0.098 | 0.203 | Antiamyloidogenic | | |
| 0.106 | 0.003 | 0.106 | Prostaglandin EP2 agonist | | |
| 0.139 | 0.039 | 0.139 | Photosensitizer | | |
| 0.105 | 0.006 | 0.105 | Alpha-mannosidase inhibitor | | |
| 0.132 | 0.033 | 0.132 | DOPA decarboxylase inhibitor | | |
| 0.11 | 0.012 | 0.11 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | | |
| 0.1 | 0.003 | 0.1 | Leukotriene C4 antagonist | | |
| 0.119 | 0.022 | 0.119 | Keratolytic | | |
| 0.116 | 0.019 | 0.116 | Thioredoxin reductase inhibitor | | |
| 0.129 | 0.032 | 0.129 | Prolactin inhibitor | | |
| 0.222 | 0.126 | 0.222 | Insulysin inhibitor | | |
| 0.159 | 0.063 | 0.159 | GABA C receptor rho-2 antagonist | | |
| 0.13 | 0.034 | 0.13 | Creatine kinase inhibitor | | |
| 0.158 | 0.062 | 0.158 | Thiol protease inhibitor | | |
| 0.137 | 0.043 | 0.137 | 5-Lipoxygenase inhibitor | | |
| 0.143 | 0.05 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | | |
| 0.103 | 0.009 | 0.103 | Glutamate (mGluR6) antagonist | | |
| 0.112 | 0.021 | 0.112 | Interferon agonist | | |
| 0.093 | 0.002 | 0.093 | Prostaglandin F2 alpha agonist | | |
| 0.096 | 0.006 | 0.096 | Peroxisome proliferator-activated receptor delta agonist | | |
| 0.112 | 0.022 | 0.112 | Na+ K+ transporting ATPase inhibitor | | |
| 0.094 | 0.005 | 0.094 | Lysophosphatidic acid 3 receptor antagonist | | |
| 0.096 | 0.008 | 0.096 | Diacylglycerol O-acyltransferase inhibitor | | |
| 0.088 | 0.003 | 0.088 | Prostaglandin D2 agonist | | |
| 0.118 | 0.033 | 0.118 | Lanosterol 14 alpha demethylase inhibitor | | |
| 0.142 | 0.058 | 0.142 | Interleukin 4 antagonist | | |
| 0.106 | 0.023 | 0.106 | GABA aminotransferase inhibitor | | |
| 0.101 | 0.019 | 0.101 | Ribonucleoside-diphosphate reductase inhibitor | | |
| 0.123 | 0.041 | 0.123 | Gastric antisecretory | | |
| 0.086 | 0.005 | 0.086 | Membrane dipeptidase inhibitor | | |
| 0.102 | 0.02 | 0.102 | Ribonucleotide reductase inhibitor | | |
| 0.095 | 0.014 | 0.095 | Autotaxin inhibitor | | |
| 0.134 | 0.054 | 0.134 | Papain-like protease (SARS coronavirus) inhibitor | | |
| 0.109 | 0.029 | 0.109 | ATPase (Vacuolar H+) inhibitor | | |
| 0.094 | 0.015 | 0.094 | Toll-Like receptor 2 agonist | | |
| 0.083 | 0.008 | 0.083 | Squalene synthetase inhibitor | | |
| 0.095 | 0.021 | 0.095 | GABA B receptor agonist | | |
| 0.129 | 0.056 | 0.129 | Protein-tyrosine phosphatase 1B inhibitor | | |
| 0.132 | 0.06 | 0.132 | DNA polymerase I inhibitor | | |
| 0.102 | 0.03 | 0.102 | Glycine receptor antagonist | | |
| 0.089 | 0.017 | 0.089 | Interferon inducer | | |
| 0.084 | 0.013 | 0.084 | Sphingosine kinase inhibitor | | |
| 0.129 | 0.058 | 0.129 | Sphingosine 1-phosphate receptor 4 antagonist | | |
| 0.09 | 0.02 | 0.09 | Purinergic P2X1 antagonist | | |
| 0.093 | 0.023 | 0.093 | Vanilloid 4 agonist | | |
| 0.128 | 0.061 | 0.128 | Alkylator | | |
| 0.107 | 0.04 | 0.107 | Phosphodiesterase 6D inhibitor | | |
| 0.07 | 0.004 | 0.07 | Kainate receptor agonist | | |
| 0.084 | 0.02 | 0.084 | Exportin-1 inhibitor | | |
| 0.177 | 0.114 | 0.177 | Cyclic AMP phosphodiesterase inhibitor | | |
| 0.071 | 0.007 | 0.071 | HIV-1 protease inhibitor | | |
| 0.085 | 0.022 | 0.085 | Neuraminidase inhibitor | | |
| 0.074 | 0.011 | 0.074 | Adenosine deaminase inhibitor | | |
| 0.101 | 0.04 | 0.101 | Glutamate release inhibitor | | |
| 0.068 | 0.008 | 0.068 | Arginase inhibitor | | |
| 0.094 | 0.034 | 0.094 | Estrogen-related receptor beta agonist | | |
| 0.142 | 0.083 | 0.142 | Acetylcholine M1 receptor antagonist | | |
| 0.079 | 0.021 | 0.079 | MDM2 inhibitor | | |
| 0.059 | 0.002 | 0.059 | Thromboxane agonist | | |
| 0.061 | 0.003 | 0.061 | G-protein-coupled receptor 120 agonist | | |
| 0.106 | 0.049 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | | |
| 0.063 | 0.007 | 0.063 | Prostaglandin EP4 antagonist | | |
| 0.064 | 0.008 | 0.064 | Prostaglandin EP3 antagonist | | |
| 0.07 | 0.015 | 0.07 | Adenine nucleotide translocase inhibitor | | |
| 0.069 | 0.014 | 0.069 | Vanilloid 2 antagonist | | |
| 0.077 | 0.024 | 0.077 | Cathepsin E inhibitor | | |
| 0.09 | 0.038 | 0.09 | Cathepsin G inhibitor | | |
| 0.055 | 0.004 | 0.055 | Lysophosphatidic acid receptor 1 agonist | | |
| 0.055 | 0.003 | 0.055 | Prostaglandin H2 antagonist | | |
| 0.102 | 0.05 | 0.102 | Alcohol dehydrogenase inhibitor | | |
| 0.082 | 0.032 | 0.082 | Phospholipase D inhibitor | | |
| 0.099 | 0.051 | 0.099 | Bile acid receptor antagonist | | |
| 0.052 | 0.004 | 0.052 | Lysophosphatidic acid 1 receptor antagonist | | |
| 0.06 | 0.013 | 0.06 | Sphingosine 1-phosphate receptor 1 agonist | | |
| 0.056 | 0.01 | 0.056 | Glucagon-like peptide 1 receptor antagonist | | |
| 0.049 | 0.003 | 0.049 | Vitamin D receptor agonist | | |
| 0.055 | 0.009 | 0.055 | Glutamate (mGluR8) agonist | | |
| 0.076 | 0.031 | 0.076 | Beta adrenoreceptor antagonist | | |
| 0.056 | 0.011 | 0.056 | Acetyl-CoA transferase 1 inhibitor | | |
| 0.061 | 0.018 | 0.061 | Macrophage elastase inhibitor | | |
| 0.065 | 0.021 | 0.065 | Pregnane X receptor antagonist | | |
| 0.055 | 0.012 | 0.055 | Sphingosine kinase 1 inhibitor | | |
| 0.051 | 0.009 | 0.051 | Peroxisome proliferator-activated receptor delta antagonist | | |
| 0.053 | 0.012 | 0.053 | p53 inhibitor | | |
| 0.07 | 0.029 | 0.07 | Cathepsin D inhibitor | | |
| 0.051 | 0.01 | 0.051 | Glucagon receptor antagonist | | |
| 0.073 | 0.032 | 0.073 | Neuraminidase (influenza) inhibitor | | |
| 0.051 | 0.01 | 0.051 | Purinergic P2X3 antagonist | | |
| 0.088 | 0.048 | 0.088 | Adrenaline agonist | | |
| 0.128 | 0.088 | 0.128 | Mannose-6-phosphate isomerase inhibitor | | |
| 0.06 | 0.021 | 0.06 | Squalene epoxidase inhibitor | | |
| 0.055 | 0.017 | 0.055 | Guanylate cyclase inhibitor | | |
| 0.056 | 0.018 | 0.056 | Cytokine production stimulant | | |
| 0.185 | 0.148 | 0.185 | Neuropeptide Y2 antagonist | | |
| 0.061 | 0.023 | 0.061 | Beta 2 adrenoreceptor antagonist | | |
| 0.045 | 0.009 | 0.045 | Lysine carboxypeptidase inhibitor | | |
| 0.056 | 0.02 | 0.056 | Sphingosine 1-phosphate receptor agonist | | |
| 0.045 | 0.009 | 0.045 | Carboxypeptidase B inhibitor | | |
| 0.039 | 0.003 | 0.039 | Lysophosphatidic acid receptor 3 agonist | | |
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | | |
| 0.056 | 0.02 | 0.056 | Leukocyte elastase inhibitor | | |
| 0.045 | 0.01 | 0.045 | Cholesterol ester transfer protein antagonist | | |
| 0.134 | 0.099 | 0.134 | Heat shock protein 70 antagonist | | |
| 0.06 | 0.025 | 0.06 | Immunoglobulin Fc receptor antagonist | | |
| 0.051 | 0.017 | 0.051 | Renin inhibitor | | |
| 0.039 | 0.005 | 0.039 | Toll-Like receptor 4 agonist | | |
| 0.075 | 0.041 | 0.075 | Elastase 1 inhibitor | | |
| 0.036 | 0.003 | 0.036 | Thromboxane A2 agonist | | |
| 0.05 | 0.018 | 0.05 | Retinoid X receptor agonist | | |
| 0.061 | 0.029 | 0.061 | Acetyl-CoA transferase 2 inhibitor | | |
| 0.066 | 0.034 | 0.066 | Carbonic anhydrase stimulant | | |
| 0.052 | 0.02 | 0.052 | Neuraminidase (Influenza A) inhibitor | | |
| 0.06 | 0.029 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | | |
| 0.06 | 0.028 | 0.06 | Prostaglandin E2 antagonist | | |
| 0.037 | 0.006 | 0.037 | Leukotriene B4 receptor 2 antagonist | | |
| 0.064 | 0.033 | 0.064 | Beta 2 adrenoreceptor agonist | | |
| 0.04 | 0.009 | 0.04 | Peroxisome proliferator-activated receptor alpha antagonist | | |
| 0.072 | 0.041 | 0.072 | Selectin antagonist | | |
| 0.057 | 0.026 | 0.057 | Bombesin 2 receptor antagonist | | |
| 0.049 | 0.019 | 0.049 | Beta adrenoreceptor agonist | | |
| 0.072 | 0.043 | 0.072 | Sphingosine 1-phosphate receptor 4 agonist | | |
| 0.071 | 0.042 | 0.071 | Glutamate (mGluR7) antagonist | | |
| 0.062 | 0.034 | 0.062 | Beta 1 adrenoreceptor antagonist | | |
| 0.039 | 0.011 | 0.039 | Glutamate (mGluR3) agonist | | |
| 0.032 | 0.004 | 0.032 | Carbonic anhydrase VIII inhibitor | | |
| 0.032 | 0.004 | 0.032 | Carbonic anhydrase X inhibitor | | |
| 0.038 | 0.01 | 0.038 | Elastase 3B inhibitor | | |
| 0.038 | 0.01 | 0.038 | Elastase 2B inhibitor | | |
| 0.038 | 0.01 | 0.038 | Elastase 3A inhibitor | | |
| 0.039 | 0.011 | 0.039 | Calcium-independent phospholipase A2 inhibitor | | |
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | | |
| 0.052 | 0.025 | 0.052 | Microtubule stabilization | | |
| 0.057 | 0.03 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | | |
| 0.043 | 0.016 | 0.043 | Prostacyclin antagonist | | |
| 0.075 | 0.049 | 0.075 | CDC25A inhibitor | | |
| 0.028 | 0.003 | 0.028 | Methylmalonyl-CoA mutase inhibitor | | |
| 0.049 | 0.024 | 0.049 | Geranyltranstransferase inhibitor | | |
| 0.042 | 0.018 | 0.042 | Phosphoglycerate kinase inhibitor | | |
| 0.084 | 0.061 | 0.084 | Hematopoietic | | |
| 0.027 | 0.006 | 0.027 | Neuraminidase (Influenza B) inhibitor | | |
| 0.028 | 0.007 | 0.028 | Free fatty acid receptor 1 agonist | | |
| 0.035 | 0.016 | 0.035 | Lysophosphatidic acid 2 receptor antagonist | | |
| 0.041 | 0.022 | 0.041 | Retinoid X receptor antagonist | | |
| 0.041 | 0.024 | 0.041 | G protein-coupled receptor agonist | | |
| 0.029 | 0.011 | 0.029 | Vanilloid 2 agonist | | |
| 0.028 | 0.01 | 0.028 | Prostaglandin EP1 antagonist | | |
| 0.038 | 0.021 | 0.038 | Glutamate (mGluR8) antagonist | | |
| 0.061 | 0.044 | 0.061 | Caspase 9 inhibitor | | |
| 0.024 | 0.007 | 0.024 | Ileal bile acid transport inhibitor | | |
| 0.054 | 0.038 | 0.054 | Angiotensin-converting enzyme inhibitor | | |
| 0.047 | 0.031 | 0.047 | Adenylate cyclase 1 inhibitor | | |
| 0.037 | 0.022 | 0.037 | Calcitonin receptor agonist | | |
| 0.053 | 0.038 | 0.053 | Elastase inhibitor | | |
| 0.038 | 0.023 | 0.038 | Glutamate (mGluR3) antagonist | | |
| 0.039 | 0.024 | 0.039 | 5-Alpha-reductase inhibitor | | |
| 0.036 | 0.021 | 0.036 | Retinoid X alpha receptor antagonist | | |
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | | |
| 0.021 | 0.007 | 0.021 | Telomerase stimulant | | |
| 0.036 | 0.023 | 0.036 | Retinoid X alpha receptor agonist | | |
| 0.033 | 0.02 | 0.033 | Methionyl aminopeptidase 1 inhibitor | | |
| 0.024 | 0.011 | 0.024 | Vitamin D receptor antagonist | | |
| 0.093 | 0.081 | 0.093 | Monophenol monooxygenase inhibitor | | |
| 0.038 | 0.027 | 0.038 | Vanilloid 3 antagonist | | |
| 0.051 | 0.041 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | | |
| 0.03 | 0.02 | 0.03 | Plasmepsin I inhibitor | | |
| 0.046 | 0.036 | 0.046 | Cholesterol esterase inhibitor | | |
| 0.045 | 0.035 | 0.045 | Antimetabolite | | |
| 0.092 | 0.083 | 0.092 | Folate antagonist | | |
| 0.028 | 0.019 | 0.028 | Hypoxanthine phosphoribosyltransferase inhibitor | | |
| 0.081 | 0.072 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | | |
| 0.04 | 0.032 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | | |
| 0.043 | 0.036 | 0.043 | Endothelin-converting enzyme inhibitor | | |
| 0.182 | 0.175 | 0.182 | Hypoxia-inducible factor 1 alpha inhibitor | | |
| 0.056 | 0.049 | 0.056 | Ryanodine receptor antagonist | | |
| 0.015 | 0.008 | 0.015 | 5 Lipoxygenase activating protein inhibitor | | |
| 0.058 | 0.051 | 0.058 | NMDA receptor agonist | | |
| 0.041 | 0.035 | 0.041 | AICAR transformylase inhibitor | | |
| 0.022 | 0.016 | 0.022 | Isoleucine-tRNA ligase inhibitor | | |
| 0.054 | 0.048 | 0.054 | Cannabinoid CB1 receptor agonist | | |
| 0.055 | 0.049 | 0.055 | Lipocortins synthesis agonist | | |
| 0.056 | 0.051 | 0.056 | Glucagon-like peptide 1 agonist | | |
| 0.021 | 0.015 | 0.021 | Neutral endopeptidase inhibitor | | |
| 0.013 | 0.007 | 0.013 | Glutamate (mGluR6) agonist | | |
| 0.017 | 0.013 | 0.017 | Aminopeptidase A inhibitor | | |
| 0.074 | 0.069 | 0.074 | Calcium antagonist | | |
| 0.026 | 0.021 | 0.026 | Retinoid X gamma receptor antagonist | | |
| 0.009 | 0.005 | 0.009 | Mannitol 2-dehydrogenase inhibitor | | |
| 0.022 | 0.017 | 0.022 | Prostaglandin D2 antagonist | | |
| 0.053 | 0.049 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | | |
| 0.012 | 0.007 | 0.012 | Carboxypeptidase B2 inhibitor | | |
| 0.043 | 0.039 | 0.043 | GP IIb/IIIa receptor antagonist | | |
| 0.056 | 0.052 | 0.056 | HIV-1 integrase (3'-Processing) inhibitor | | |
| 0.097 | 0.094 | 0.097 | Beta amyloid protein antagonist | | |
| 0.036 | 0.033 | 0.036 | Retinoic acid alpha receptor agonist | | |
| 0.075 | 0.072 | 0.075 | Androgen antagonist | | |
| 0.021 | 0.019 | 0.021 | Beta 1 adrenoreceptor agonist | | |
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | | |